These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 16171037)
21. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study. Braun KP; van Eijsden P; Vandertop WP; de Graaf RA; Gooskens RH; Tulleken KA; Nicolay K J Neurosurg; 1999 Oct; 91(4):660-8. PubMed ID: 10507389 [TBL] [Abstract][Full Text] [Related]
22. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings. Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542 [TBL] [Abstract][Full Text] [Related]
23. Clinical perspectives of hybrid proton-fluorine magnetic resonance imaging and spectroscopy. Wolters M; Mohades SG; Hackeng TM; Post MJ; Kooi ME; Backes WH Invest Radiol; 2013 May; 48(5):341-50. PubMed ID: 23211551 [TBL] [Abstract][Full Text] [Related]
24. Prostate cancer in magnetic resonance imaging: diagnostic utilities of spectroscopic sequences. Caivano R; Cirillo P; Balestra A; Lotumolo A; Fortunato G; Macarini L; Zandolino A; Vita G; Cammarota A J Med Imaging Radiat Oncol; 2012 Dec; 56(6):606-16. PubMed ID: 23210579 [TBL] [Abstract][Full Text] [Related]
25. MR imaging and MR spectroscopic imaging of prostate cancer. Rajesh A; Coakley FV Magn Reson Imaging Clin N Am; 2004 Aug; 12(3):557-79, vii. PubMed ID: 15271371 [TBL] [Abstract][Full Text] [Related]
26. Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Tran TK; Vigneron DB; Sailasuta N; Tropp J; Le Roux P; Kurhanewicz J; Nelson S; Hurd R Magn Reson Med; 2000 Jan; 43(1):23-33. PubMed ID: 10642728 [TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance spectroscopy in prostate disease: diagnostic possibilities and future developments. Narayan P; Kurhanewicz J Prostate Suppl; 1992; 4():43-50. PubMed ID: 1374177 [TBL] [Abstract][Full Text] [Related]
28. V.3. Basic elements of nuclear magnetic resonance for use in medical diagnostics: Magnetic Resonance Imaging (MRI), magnetic resonance spectroscopy (MRS). Niederer PF Stud Health Technol Inform; 2010; 152():302-20. PubMed ID: 20407201 [TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance spectroscopy in psychiatry: potential, pitfalls, and promise. Keshavan MS; Kapur S; Pettegrew JW Am J Psychiatry; 1991 Aug; 148(8):976-85. PubMed ID: 1853987 [TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance spectroscopic imaging (1H-MRSI) and dynamic contrast-enhanced magnetic resonance (DCE-MRI): pattern changes from inflammation to prostate cancer. Sciarra A; Panebianco V; Ciccariello M; Salciccia S; Lisi D; Osimani M; Alfarone A; Gentilucci A; Parente U; Passariello R; Gentile V Cancer Invest; 2010 May; 28(4):424-32. PubMed ID: 20073578 [TBL] [Abstract][Full Text] [Related]
32. Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection. Perdonà S; Di Lorenzo G; Autorino R; Buonerba C; De Sio M; Setola SV; Fusco R; Ronza FM; Caraglia M; Ferro M; Petrillo A Urol Oncol; 2013 Aug; 31(6):761-5. PubMed ID: 21906966 [TBL] [Abstract][Full Text] [Related]